Back
Paramount Gold Nevada 10K Form
Sell
12
PZG
Paramount Gold Nevada
Last Price:
$0.34
Seasonality Move:
-2.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-14 | 10Q | PZG/Paramount Gold Nevada Quarterly |
| 2024-02-13 | 10Q | PZG/Paramount Gold Nevada Quarterly |
| 2023-11-09 | 10Q | PZG/Paramount Gold Nevada Quarterly |
| 2023-09-26 | 10K | PZG/Paramount Gold Nevada Annual |
| 2023-05-12 | 10Q | PZG/Paramount Gold Nevada Quarterly |
| 2023-02-10 | 10Q | PZG/Paramount Gold Nevada Quarterly |
Receive PZG News And Ratings
See the #1 stock for the next 7 days that we like better than PZG
PZG Financial Statistics
Sales & Book Value
| Annual Sales: | $340K |
|---|---|
| Cash Flow: | $-1.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.56 |
| Price / Book: | 0.61 |
Profitability
| EPS (TTM): | -0.12000 |
|---|---|
| Net Income (TTM): | $-7.6M |
| Gross Margin: | $-647.5K |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Paramount Gold Nevada Earnings Forecast
Key Paramount Gold Nevada Financial Ratios
-
The Selling, General & Administrative Expenses for PZG have been equal to 450.79% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is -14.45% of Operating Income.
-
Per Share Earnings over the last 19 years have been positive in 9 years.
Paramount Gold Nevada Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Metals & Mining |
| Sector: | Materials |
| Current Symbol: | PZG |
| CUSIP: | 69924M |
| Website: | paramountnevada.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PZG Technical Analysis vs Fundamental Analysis
Sell
12
Paramount Gold Nevada (PZG)
is a Sell
Is Paramount Gold Nevada a Buy or a Sell?
-
Paramount Gold Nevada stock is rated a SellThe current Paramount Gold Nevada [PZG] share price is $0.34. The Score for PZG is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.